Timothy M. Mayleben is CEO & President at Esperion Therapeutics, Inc. (ESPR). They have made 25 open-market trades across 4 companies since 2006, most recently 2025-02-11.
CIK 0001242613
22 open-market purchases totalling $3.3M since 2006, against 3 sales. Across 14 scored buys the stock is up 12.9% at ninety days, and 7.0 points ahead of the S&P over the same stretch.
14 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 57% | 50% | 71% |
| Avg Move | -2.8% | +0.8% | +12.9% |
| Alpha | -1.0% | +0.7% | +7.0% |
| Scored | 14 | 14 | 14 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ESPR | BUY | 2020-03-11 | 2020-03-12 | $43.00 | $108K | +4.7% | -0.9% | +29.1% |
| ESPR | BUY | 2020-02-28 | 2020-03-02 | $49.00 | $245K | -32.9% | -42.4% | -19.3% |
| ESPR | BUY | 2019-11-06 | 2019-11-08 | $36.98 | $370K | +17.6% | +30.4% | +52.3% |
| ESPR | BUY | 2019-09-04 | 2019-09-06 | $34.55 | $259K | +3.8% | +5.1% | +32.4% |
| ESPR | BUY | 2019-09-04 | 2019-09-06 | $34.22 | $166K | +3.8% | +5.1% | +32.4% |
| ESPR | BUY | 2019-08-01 | 2019-08-02 | $39.56 | $198K | -3.1% | -9.9% | +2.6% |
| ESPR | BUY | 2019-06-28 | 2019-07-01 | $46.00 | $230K | -2.1% | -14.6% | -21.2% |
| ESPR | BUY | 2019-03-29 | 2019-04-01 | $40.00 | $200K | +3.5% | +2.7% | +11.4% |
| ESPR | BUY | 2019-03-20 | 2019-03-21 | $43.48 | $435K | -2.2% | -6.0% | +14.1% |
| ESPR | BUY | 2019-03-14 | 2019-03-14 | $48.73 | $487K | -14.9% | -16.0% | +0.1% |
| LOXO | SELL | 2018-06-08 | 2018-06-11 | $179.55 | $1.8M | +1.7% | +0.3% | -8.5% |
| LOXO | SELL | 2017-12-20 | 2017-12-22 | $80.49 | $805K | -1.6% | +19.2% | +34.0% |
| LOXO | SELL | 2017-11-22 | 2017-11-27 | $75.85 | $455K | +6.7% | +15.5% | +51.0% |
| ESPR | BUY | 2016-05-04 | 2016-05-05 | $14.85 | $104K | +3.1% | +30.2% | -20.8% |
| ESPR | BUY | 2016-01-27 | 2016-01-28 | $15.88 | $57K | +0.6% | +4.6% | +21.1% |
| ESPR | BUY | 2016-01-15 | 2016-01-19 | $14.08 | $101K | +15.0% | +23.4% | +46.4% |
| ESPR | BUY | 2013-07-01 | 2013-07-01 | $14.00 | $70K | -35.3% | -0.8% | -0.8% |
| ASTM | BUY | 2011-08-08 | 2011-08-09 | $2.11 | $21K | N/A | N/A | N/A |
| ASTM | BUY | 2011-08-05 | 2011-08-08 | $2.36 | $47K | N/A | N/A | N/A |
| ASTM | BUY | 2011-03-02 | 2011-03-04 | $2.12 | $45K | N/A | N/A | N/A |
| ASTM | BUY | 2010-11-24 | 2010-11-29 | $2.20 | $26K | N/A | N/A | N/A |
| ASTM | BUY | 2010-08-30 | 2010-08-31 | $1.45 | $25K | N/A | N/A | N/A |
| ASTM | BUY | 2010-05-21 | 2010-05-25 | $1.42 | $25K | N/A | N/A | N/A |
| ASTM | BUY | 2010-03-05 | 2010-03-09 | $1.46 | $50K | N/A | N/A | N/A |
| NHWK | BUY | 2006-08-15 | 2006-08-17 | $16.29 | $65K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.